本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aerovate Therapeutics, Inc.

2.80
+0.03001.08%
成交量:65.56万
成交额:184.74万
市值:8,115.81万
市盈率:-1.15
高:2.86
开:2.80
低:2.78
收:2.77
数据加载中...
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/30

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities